HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Malnutrition ‘almost epidemic’ among patients with advanced cancer
-
- Abemaciclib regimen extends PFS among certain women with advanced breast cancer
- Addition of ublituximab to ibrutinib improves response in high-risk CLL
- Array, Merck to collaborate on trial of binimetinib, pembrolizumab for metastatic colorectal cancer
- University of Michigan prostate cancer risk clinic may make ‘dramatic impact’ on disease burden, mortality
- Children’s Hospital of Philadelphia appoints section chief
- Conquer Cancer Foundation of ASCO to present awards
- Counseling visit impacts patients’ decision to undergo lung cancer screening
- Dana-Farber Cancer Institute appoints gastrointestinal cancer center director
-
- Failed confirmatory trial raises questions about atezolizumab for advanced urothelial cancer
- Federal budget proposal would deal ‘devastating blow’ to medical research
- Fox Chase Cancer Center appoints assistant professor of thoracic surgery
- Light-scattering tool may improve early identification of pancreatic cancer
- Loyola Medicine appoints vice chair in radiation oncology department
- National repository offers ‘endless’ potential for hemophilia research
- Patient education pivotal when recommending palliative care
- Society recognizes St. Jude Children’s Research Hospital president, CEO
-
- Winship Cancer Institute joins elite status of NCI–designated comprehensive cancer centers
- ‘Covfefe’ — the real meaning Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA clears marketing of scalp-cooling system to reduce chemotherapy-associated hair loss
- FDA advisory committee expresses support for three therapies
- FDA clears marketing of scalp-cooling system to reduce chemotherapy-associated hair loss
- FDA grants accelerated approval to brigatinib for ALK–positive NSCLC
- FDA grants Lynparza priority review for maintenance treatment of ovarian cancer
- FDA issues warnings about fraudulent cancer treatments
-
- Active surveillance of prostate cancer associated with favorable outcomes in younger men
- Addition of bortezomib to lenalidomide, dexamethasone improves myeloma survival
- Addition of cetuximab improves outcomes in KRAS-variant HNSCC
- Apixaban lowers risk for intracranial hemorrhages in patients with atrial fibrillation
- Biosimilar may provide affordable, effective trastuzumab alternative
- Complete response at 30 months serves as surrogate endpoint in follicular lymphoma
- Complete surgical metastasectomy improves survival in late-stage renal cell carcinoma
- Despite requests, many women with breast cancer do not receive genetic tests
-
- F. nucleatum associated with poor survival in esophageal cancer
- Few women with early-stage breast cancer seek second opinion
- Hematopoietic cell transplant survivors face greater late morbidity, mortality
- Homologous recombination deficiency analysis predicts PARP inhibitor benefit for ovarian cancer
- Incidence, prevalence of neuroendocrine tumors on the rise
- Inflammatory bowel disease a risk factor for VTE in pregnant women
- Longer-interval zoledronic acid dosing noninferior to standard dosing for bone metastases
- Men with HIV, nonmelanoma skin cancer at greater risk for Kaposi’s sarcoma
-
- Minimal residual disease negativity associated with longer survival in ALL
- Older patients with NSCLC experience high treatment burden
- Pembrolizumab exhibits antitumor activity in recurrent HNSCC
- Rivaroxaban noninferior to fondaparinux for superficial vein thrombosis
- Selumetinib appears beneficial for children with inoperable plexiform neurofibromas
- Updated ASTRO guideline expands pool of accelerated partial breast irradiation candidates
- Young patients experience poor social functioning years after cancer diagnosis
- Younger age associated with genetic alterations in lung adenocarcinoma
-
- Affordable Care Act increases screening, early diagnosis of certain cancers
- Alvimopan may shorten hospital stays after surgery for testicular cancer
- E-cigarettes may increase bladder cancer risk
- Exercise, healthy diet extend colon cancer survival
- HPV vaccination confers high degree of protection against oral infections, despite underuse
- Low testosterone levels prevalent among testicular cancer survivors
- New molecules may offer next-generation treatment in prostate cancer
- Psychological intervention reduces cancer survivors’ fear of recurrence
-
- Single-dose radiotherapy should be standard for metastatic spinal canal compression
- Effective pharmacological management of depression ‘imperative’ for patients with cancer Jai N. Patel, PharmD, BCOP, CPP
- Do the benefits of a feeding tube outweigh the risks for a malnourished patient with cancer treated with curative intent?